To assess the validity of our linear transcript data regarding the BCR prediction, we used The Cancer Genome Atlas Prostate Cancer (TCGA-PRAD) dataset, a publicly available dataset (Table S17). The gene discussed is BCR; the disease is prostate carcinoma.